Covered recipient · General Payments record
SYDNEY MALONE HANSON
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$9,592.17
- Reported across 71 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Travel and Lodging | $2,523.63 | 7 |
| Food and Beverage | $1,054.15 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $1,917.26 | 8 |
| LivaNova USA, Inc. | $1,559.40 | 7 |
| Nevro Corp. | $70.17 | 1 |
| ABBVIE INC. | $30.95 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $194.95 | 03/07/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1125403839 | CMS |
| Abbott Laboratories | $66.25 | 03/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124997387 | CMS |
| Abbott Laboratories | $703.84 | 03/26/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1125403841 | CMS |
| Abbott Laboratories | $163.61 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124997381 | CMS |
| Abbott Laboratories | $741.20 | 05/01/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1125403837 | CMS |
| Abbott Laboratories | $9.02 | 05/01/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1125403843 | CMS |
| Abbott Laboratories | $28.52 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124997383 | CMS |
| Abbott Laboratories | $9.87 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124997385 | CMS |
| ABBVIE INC. | $30.95 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107286768 | CMS |
| LivaNova USA, Inc. | $165.51 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152794479 | CMS |
| LivaNova USA, Inc. | $168.92 | 04/05/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1152794571 | CMS |
| LivaNova USA, Inc. | $219.70 | 04/05/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1152794573 | CMS |
| LivaNova USA, Inc. | $486.00 | 04/05/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1152794575 | CMS |
| LivaNova USA, Inc. | $184.97 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152794577 | CMS |
| LivaNova USA, Inc. | $175.77 | 04/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152794579 | CMS |
| LivaNova USA, Inc. | $158.53 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152794533 | CMS |
| Nevro Corp. | $70.17 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130763513 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.